Abstract: A system and a method is for automating welding processes, in particular welding processes in the heavy industries. One embodiment regards a computer implemented method for automatic detection and/or planning of a welding task in a welding environment, the method including the steps of: obtaining scanning data from a scan of the welding environment, detecting welding object(s) in the scanning data by means of artificial intelligence employing a machine learning algorithm, wherein the machine learning algorithm has been trained on real and simulated 3D data of known welding objects, determining the pose of each detected welding object, and optionally generating a welding path for each detected welding object.

Abstract: A method and a system for controlling a welding operation is provided by a welding machine controlled by an automatic motion generating mechanism. The method includes the steps of acquiring a set of welding data during the welding operation; computing at least a first part of the set of welding data and at least a second part of the set of welding data providing computed data, wherein the computed data indicate an abnormality; and transferring an abnormality output to a robot controller, which is controlling the welding machine and the automatic motion generating mechanism.

Abstract: A filter press having a plurality of stackable filter plate assemblies comprises at least one turbidity sensing module [20, 220, 320, 420] coupled to a first filter plate assembly [1] within the plurality of stackable filter plate assemblies. The turbidity sensing module [20, 220, 320, 420] is generally positioned between a filtrate drain opening [8a-d] communicating with a filter chamber [14], and either a filtrate port [7, 13] or filtrate discharge tube [4g, 15], in order to determine a level of turbidity of filtrate [50] exiting said first filter plate assembly. Turbidity levels may be determined independently of turbidity levels of filtrate [50] exiting other filter plate assemblies [1] within the filter press. When turbidity levels reach a predetermined threshold, and alarm [80] is activated, which informs an operator of the need to replace a filter cloth associated with the affected filter plate assembly [1].

Abstract: A filter press having a plurality of stackable filter plate assemblies comprises at least one turbidity sensing module [20, 220, 320, 420] coupled to a first filter plate assembly [1] within the plurality of stackable filter plate assemblies. The turbidity sensing module [20, 220, 320, 420] is generally positioned between a filtrate drain opening [8a-d] communicating with a filter chamber [14], and either a filtrate port [7, 13] or filtrate discharge tube [4g, 15], in order to determine a level of turbidity of filtrate [50] exiting said first filter plate assembly. Turbidity levels may be determined independently of turbidity levels of filtrate [50] exiting other filter plate assemblies [1] within the filter press. When turbidity levels reach a predetermined threshold, and alarm [80] is activated, which informs an operator of the need to replace a filter cloth associated with the affected filter plate assembly [1].

Abstract: The present invention pertains to a composition for the manufacture of a medicament comprising living or dead bacteria with controlled amounts of surface-coupled proteins or proteinaceous compounds and a method for the preparation of the composition. The bacterium provides a multivalent heterologous protein display vehicle that may be used in the manufacture of vaccines or medicaments for delivery via the mucosa.

Abstract: The present invention concerns a new ?-galactosidase with transgalactosylating activity isolated from Bifidobacterium bifidum and a truncated enzyme where the C-terminal end of the ?-galactosidase protein has been deleted, resulting in an enzyme with a higher transgalactosylating activity than hydrolase activity. When lactose is used as a substrate, galacto-oligosaccharides are products of the transgalactosylase activity. Galacto-oligosaccharides enhance growth of health-promoting Bifidobacterium that may be used in a number of applications in the dairy industry.

Abstract: A novel L-arabinose isomerase active enzyme and its corresponding gene, derived from a thermophilic source are provided. The enzyme is suitable for the production of D-tagatose, a useful low-calorie sweetener. The enzyme may be obtained from a Thermoanaerobacter species such as Thermoanaerobacter mathranii.

Abstract: Tagatose is manufactured by hydrolyzing lactose to galactose and glucose and isomerizing galactose to tagatose and chromatographic separation and recycling any unconverted compounds. Thereby high yields of pure tagatose are obtained.

Abstract: The present invention concerns a new &bgr;-galactosidase with transgalactosylating activity isolated from Bifidobacterium bifidum and a truncated enzyme where the C-terminal end of the &bgr;-galactosidase protein has been deleted, resulting in an enzyme with a higher transgalactosylating activity than hydrolase activity. When lactose is used as a substrate, galacto-oligosaccharides are products of the transgalactosylase activity. Galacto-oligosaccharides enhance growth of health-promoting Bifidobacterium that may be used in a number of applications in the dairy industry.

Abstract: A novel L-arabinose isomerase active enzyme and its corresponding gene, derived from a thermophilic source are provided. The enzyme is suitable for the production of D-tagatose, a useful low-calorie sweetener. The enzyme may be obtained from a Thermoanaerobacter species such as Thermoanaerobacter mathranii.

Abstract: The present invention concerns a new &bgr;-galactosidase with transgalactosylating activity isolated from Bifidobacterium bifidum and a truncated enzyme where the C-terminal end of the &bgr;-galactosidase protein has been deleted, resulting in an enzyme with a higher transgalactosylating activity than hydrolase activity. When lactose is used as a substrate, galacto-oligosaccharides are products of the transgalactosylase activity. Galacto-oligosaccharides enhance growth of health-promoting Bifidobacterium that may be used in a number of applications in the dairy industry.

Abstract: Tagatose is manufactured by hydrolyzing lactose to galactose and glucose and isomerizing galactose to tagatose and chromatographic separation and recycling any unconverted compounds. Thereby high yields of pure tagatose are obtained.

Abstract: The present invention concerns a new &bgr;-galactosidase with transgalactosylating activity isolated from Bifidobacterium bifidum and a truncated enzyme where the C-terminal end of the &bgr;-galactosidase protein has been deleted resulting in an enzyme with a higher transgalactosylating activity than hydrolase activity. When lactose is used as a substrate, galacto-oligosaccharides are products of the transgalactosylase activity. Galacto-oligosaccharides enhance growth of health-promoting Bifidobacterium that may be used in a number of applications in the diary industry.